Dr. Scott H. Okuno, MD

Dr. Okuno practices at Mayo Clinic Health System - Red Wing in Red Wing, Minnesota.

Dr. Okuno's NPI, 1750367561, was assigned on December 22, 2005. Dr. Okuno graduated from University of Illinois College of Medicine - Chicago in 1989. Dr. Okuno holds Minnesota license 33611.

Dr. Okuno's primary practice is Mayo Clinic Health System - Red Wing, at 701 Hewitt Blvd, Red Wing, MN 55066 in Goodhue County. The practice phone is (651) 267-5000.

Dr. Okuno's primary practice is Mayo Clinic Health System - Red Wing in Red Wing, Minnesota. Dr. Okuno is also affiliated with Mayo Clinic Health System in Red Wing. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Okuno to 4 more hospitals, 5 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Okuno practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Okuno's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Okuno is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Okuno's licenses on file in 15 states: Minnesota, South Dakota, Iowa, Alaska, Connecticut, Florida, Illinois, Montana, North Dakota, Arizona, Colorado, Georgia, Michigan, Texas and Wisconsin.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Okuno treats.

CMS data shows 14,860 Medicare services from Dr. Okuno across 24 procedure codes in 2024, for 358 Medicare patients. Medicare paid $321,076 for them.

CMS counts 358 Medicare patients who saw Dr. Okuno in 2024. The largest group is 65 to 74, with 187 patients. 66% of them have high blood pressure, and 62% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Okuno's median patient age at 73, with 50% women.

In 2024, Dr. Okuno wrote 540 Medicare Part D claims for 143 patients. 77% of them were for generic drugs. CMS names the drug for 373 of them, across 17 drugs with 11 or more claims each, at $821,106 in total drug cost. In 2023, CMS named 475 claims across 18 drugs.

Dr. Okuno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Okuno as offering telehealth.

Dmand AI links 94 papers to Dr. Okuno, published from 2005 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Sarcoma, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Okuno has published most often in Cancer. Dr. Okuno's most frequent co-authors are Steven I. Robinson, MD, Peter Sean Rose, MD and Brittany Siontis, MD.

Dmand AI links Dr. Okuno to 16 clinical trials, 11 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Chondrosarcoma, Mesothelioma, Malignant and Radiation Injuries. Alliance for Clinical Trials in Oncology sponsors the most, 4. Open Payments lists research payments to Dr. Okuno that name 1 trial.

CMS Open Payments shows 60 general payments to Dr. Okuno from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $25,883. It also lists 1 research payment totaling $727 in 2016, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Okuno, most recently ACP Fellow in 2002.

Dr. Okuno graduated from University of Illinois College of Medicine - Chicago in 1989. Dr. Okuno is a member of ACP and ASCO.

Dr. Okuno is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.